Location: Hollings Cancer Center 355A
Dr. Lilly, a professor of Medicine, is a noted translational researcher and urologic oncologist. He co-leads the cancer center's translational research program and sees patients with advanced prostate cancer at Hollings and the Ralph H. Johnson VA Medical Center.
Dr. Lilly is a recognized expert in the field of targeted therapeutics. Specifically, he has focused on stress response pathways that are triggered in cancer cells and which contribute to resistance to cancer therapy. Many stresses, including those generated by cancer treatment, lead cells to activate defense pathways that allow them to survive the stress. Dr. Lilly holds significant funding from the US Department of Defense and the biotech industry. His lab establishes Hollings as the headquarters of a nationwide consortium to carry out a clinical trial in men with castration-resistant prostate cancer previously treated with chemotherapy.
>> More on Michael B. Lilly, MD...
>> Return to Center Leadership home...